ストックスクリーナーアプリを入手
0.8399
0.13%
-0.0011
前日終値:
$0.841
開ける：
$0.869
24時間の取引高:
238.99K
Relative Volume:
0.43
時価総額：
$43.53M
収益：
-
当期純損益:
$-81.22M
株価収益率:
-0.2838
EPS:
-2.96
ネットキャッシュフロー:
$-74.41M
1週間 パフォーマンス:
+4.99%
1か月 パフォーマンス:
+11.99%
6か月 パフォーマンス:
+23.51%
1年 パフォーマンス:
+6.32%
1日の値動き範囲:
$0.8223
$0.869
1週間の範囲:
$0.79
$0.8895
52週間の値動き範囲:
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
XLO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.8399 | 43.59M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
415.33 | 107.98B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.21 | 59.07B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
566.59 | 59.76B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
803.47 | 49.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
335.20 | 38.56B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-06 | 開始されました | Leerink Partners | Outperform |
| 2022-12-21 | 開始されました | Chardan Capital Markets | Buy |
| 2022-01-10 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-16 | 開始されました | Cowen | Outperform |
| 2021-11-16 | 開始されました | Guggenheim | Buy |
| 2021-11-16 | 開始されました | Morgan Stanley | Overweight |
| 2021-11-16 | 開始されました | Raymond James | Outperform |
すべてを表示
Xilio Therapeutics Inc (XLO) 最新ニュース
Using R and stats models for Xilio Therapeutics Inc. forecastingJuly 2025 Rallies & Intraday High Probability Alerts - newser.com
Using flow based indicators on Xilio Therapeutics Inc.2025 Key Highlights & AI Enhanced Trading Signals - newser.com
How Xilio Therapeutics Inc. stock responds to policy changesPrice Action & Growth Focused Investment Plans - newser.com
Xilio Therapeutics Transfers Listing to Nasdaq Capital Market - The Globe and Mail
Xilio Therapeutics Announces Upcoming Presentations at the - GlobeNewswire
Xilio Therapeutics announces upcoming presentations at the Society for Immunotherapy of Cancer - MarketScreener
GlobeNewswire by Notified - The Manila Times
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting - The Manila Times
Xilio Therapeutics Announces Multiple Poster Presentations at SITC 40th Annual Meeting Including Clinical Data for Vilastobart and XTX301 - Quiver Quantitative
3 Posters at SITC Nov 6-9, 2025: Xilio Presents vilastobart, XTX301 & Masked T Cell Engagers - Stock Titan
Xilio Therapeutics to transfer listing to Nasdaq Capital Market on Monday - Investing.com
Xilio Therapeutics transfers listing of co's common stock to Nasdaq Capital Market - MarketScreener
Detecting support and resistance levels for Xilio Therapeutics Inc.Weekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com
Has Xilio Therapeutics Inc. found a price floorTrade Exit Summary & Reliable Intraday Trade Alerts - newser.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
26,000-Share Grant: Xilio Therapeutics Grants Options at $0.8326 Exercise Price - Stock Titan
Xilio Therapeutics Inc Stock Analysis and ForecastVolatility Index Analysis & AI Alerts You Can Actually Trust - earlytimes.in
What analysts say about Xilio Therapeutics Inc stockAnalyst Upgrades & Investment Timing Techniques - Early Times
What drives Xilio Therapeutics Inc stock priceResistance Breakout Alerts & Low Cost Stock Picks - Early Times
Applying chart zones and confluence areas to Xilio Therapeutics Inc.Quarterly Trade Summary & Verified Momentum Stock Ideas - newser.com
Detecting price anomalies in Xilio Therapeutics Inc. with AI2025 Technical Overview & Stock Portfolio Risk Management - newser.com
Xilio Therapeutics (NASDAQ:XLO) Stock Price Down 0.8% – What’s Next? - Defense World
Published on: 2025-09-21 20:25:05 - newser.com
Is Xilio Therapeutics Inc. a candidate for recovery playQuarterly Portfolio Summary & Daily Entry Point Alerts - newser.com
Can Xilio Therapeutics Inc expand into new marketsJuly 2025 Recap & Short-Term Trading Opportunity Alerts - خودرو بانک
Update Recap: Is Xilio Therapeutics Inc stock forming a cup and handle2025 Market Outlook & Real-Time Volume Trigger Notifications - خودرو بانک
Ranking Xilio Therapeutics Inc. among high performing stocks via tools2025 Price Targets & Scalable Portfolio Growth Ideas - newser.com
Is Xilio Therapeutics Inc. showing signs of accumulationVolume Spike & Verified Chart Pattern Signals - newser.com
Fed Meeting: How much upside does Xilio Therapeutics Inc haveTrade Volume Summary & Daily Oversold Bounce Ideas - khodrobank.com
Investment Review: How does RedCloud Holdings plc perform in inflationary periodsWeekly Stock Analysis & Free Accurate Trade Setup Notifications - khodrobank.com
Risk Hedge: Is Xilio Therapeutics Inc attractive for institutional investorsTreasury Yields & Detailed Earnings Play Alerts - خودرو بانک
Ideas Watch: Is Xilio Therapeutics Incs ROE strong enough2025 Geopolitical Influence & Reliable Price Breakout Alerts - خودرو بانک
Xilio Therapeutics Faces Nasdaq Equity Compliance Challenge - MSN
Relative strength of Xilio Therapeutics Inc. in sector analysisJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - newser.com
Aug Outlook: Is Xilio Therapeutics Inc. impacted by rising ratesIndex Update & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Risks Report: Is Xilio Therapeutics Inc attractive for institutional investorsJuly 2025 Institutional & Risk Managed Investment Entry Signals - خودرو بانک
Trend Review: What dividend growth rate does SWKH offer2025 Macro Impact & AI Based Buy/Sell Signal Reports - khodrobank.com
Xilio Therapeutics Inc (XLO) 財務データ
収益
当期純利益
現金流量
EPS
0.66%
1.24%
大文字化:
|
ボリューム (24 時間):